ISPERSE Trademark

Trademark Overview

On Tuesday, January 21, 2020, a trademark application was filed for ISPERSE with the United States Patent and Trademark Office. The USPTO has given the ISPERSE trademark a serial number of 88766777. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by PULMATRIX OPERATING COMPANY, INC.. The ISPERSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of the pulmonary system, and for the treatment and prevention of exacerbations of these diseases, disorders and conditions; pharmaceuticals used for the treatment and prevention of infections; pharmaceuticals used for the treatment and prevention of headaches and neurological conditions; drug delivery agents comprising formulations that facilitate delivery of a wide range of pharmaceuticals to the pulmonary system; drug delivery agents comprising formulations that facilitate systemic delivery of a wide range of pharmaceuticals by way of the pulmonary system
isperse

General Information

Serial Number88766777
Word MarkISPERSE
Filing DateTuesday, January 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 13, 2020

Trademark Statements

Description of MarkThe mark consists of the word "ISPERSE" with the letter "I" in light blue, the dot of the "I" in turquoise, and the wording "SPERSE" in blue, all above a light blue and blue gradient line.
Goods and ServicesPharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of the pulmonary system, and for the treatment and prevention of exacerbations of these diseases, disorders and conditions; pharmaceuticals used for the treatment and prevention of infections; pharmaceuticals used for the treatment and prevention of headaches and neurological conditions; drug delivery agents comprising formulations that facilitate delivery of a wide range of pharmaceuticals to the pulmonary system; drug delivery agents comprising formulations that facilitate systemic delivery of a wide range of pharmaceuticals by way of the pulmonary system
Pseudo MarkI SPERSE
Indication of Colors claimedThe color(s) blue, light blue, and turquoise is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePULMATRIX OPERATING COMPANY, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NamePULMATRIX OPERATING COMPANY, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 17, 2023SOU EXTENSION 5 GRANTED
Tuesday, March 7, 2023SOU EXTENSION 5 FILED
Friday, March 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2022SOU EXTENSION 4 GRANTED
Monday, November 14, 2022SOU EXTENSION 4 FILED
Monday, November 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 1, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 1, 2022SOU EXTENSION 3 FILED
Wednesday, June 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 2 GRANTED
Monday, December 6, 2021SOU EXTENSION 2 FILED
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 20, 2021SOU EXTENSION 1 FILED
Tuesday, April 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 31, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 31, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 31, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 26, 2020ASSIGNED TO LIE
Tuesday, May 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 19, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION WRITTEN
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Saturday, January 25, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 24, 2020NEW APPLICATION ENTERED

Related Keywords

isperse pharmaceuticals prevention treatment delivery pulmonary conditions system used drug agents